Watkins Tim bought CTNM
January 28, 2026 · Form 4 insider transaction
Watkins Tim bought 3,611 shares of Contineum Therapeutics, Inc. at $4.50 per share, a transaction worth $16.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,611
Price
$4.50
Total value
$16.2K
InsiderWatkins Tim
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJanuary 28, 2026
Filing dateJanuary 30, 2026
Shares owned after3,611
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.